This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Glaxo Group Limited. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Sebastian Mayer: Innovator in Drug Fusions and Conjugates
Introduction
Sebastian Mayer is a notable inventor based in Cambridgeshire, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of drug fusions and conjugates. His innovative work aims to enhance the efficacy and longevity of therapeutic agents in the bloodstream.
Latest Patents
Sebastian Mayer holds a patent related to drug fusions that have improved serum half-lives. The patent, titled "Drug fusions and conjugates," encompasses polypeptides, immunoglobulin single variable domains, and GLP and/or exendin molecules. This invention also covers various uses, formulations, compositions, and devices that incorporate these drug fusions and conjugates.
Career Highlights
Mayer is currently associated with Glaxo Group Limited, where he continues to push the boundaries of pharmaceutical innovation. His work is pivotal in developing new therapeutic strategies that can significantly impact patient care.
Collaborations
Sebastian collaborates with talented individuals such as Christopher Herring and Lucy J Holt, contributing to a dynamic research environment that fosters innovation and creativity.
Conclusion
Sebastian Mayer's contributions to drug fusions and conjugates exemplify the spirit of innovation in the pharmaceutical industry. His work not only advances scientific knowledge but also holds the potential to improve patient outcomes significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile